Home › NDC Lookup › RxCUI directory › RxCUI 1870205

NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector — RxCUI 1870205

RxNorm drug concept · Semantic clinical drug
RxCUI 1870205 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1870205
Official nameNDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asepinephrine (generic for Auvi-Q) 0.3 MG per 0.3 ML Auto-Injector; EPINEPHrine (generic for Auvi-Q) 0.3 MG in 0.3 ML Auto-Injector
FDA products mapped8
Package NDCs mapped10
Reported Medicaid activity (SDUD)28,166 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Epinephrine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Use it at the first signs of a severe allergic reaction (anaphylaxis), such as trouble breathing, swelling, hives, vomiting or feeling faint. It is for emergencies, so don't wait t...
  • For AUVI-Q, inject into the outer thigh, through clothing if needed. Never inject it into a vein, your buttock, or your fingers, hands or feet. In young children, hold the leg firm...
  • Yes. Epinephrine is emergency treatment only, not a substitute for medical care. You need monitoring, and you may need more treatment. If symptoms don't improve, a second dose can...
  • Do I still need to go to the hospital after using it?
📖 Read our full Epinephrine Injection guide →

🕸️ Concept Web — How NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Inject... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector RxCUI 1870205

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Epinephrine 3992
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Auvi-Q 1305264
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Epinephrine Auto-Injector 1661387
    • Epinephrine Injectable Product 1163887
    • Epinephrine Auto-Injector [Auvi-Q] 1661393
    • Auvi-Q Injectable Product 1305267
    • Auto-Injector 1649570
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Epinephrine 1 MG/ML SCDC · 328316
  • Epinephrine Auto-Injector SCDF · 1661387
  • Epinephrine Injectable Product SCDG · 1163887

Brand-Name Concepts

📦 FDA Products & Package NDCs

8 products · 10 package NDCs
10 package NDCs map to RxCUI 1870205 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51662-1320-01 .3 mL in 1 DOSE PACK (51662-1320-1) EPINEPHRINE HF Acquisition Co LLC, DBA HealthFirst 2018-09-21
51662-1320-02 2 DOSE PACK in 1 CARTON (51662-1320-2) / .3 mL in 1 DOSE PA... EPINEPHRINE HF Acquisition Co LLC, DBA HealthFirst 2019-08-24
51662-1321-01 .15 mL in 1 DOSE PACK (51662-1321-1) EPINEPHRINE HF Acquisition Co LLC, DBA HealthFirst 2018-09-21
51662-1321-02 2 DOSE PACK in 1 CARTON (51662-1321-2) / .15 mL in 1 DOSE P... EPINEPHRINE HF Acquisition Co LLC, DBA HealthFirst 2019-08-24
51662-1663-02 2 DOSE PACK in 1 CARTON (51662-1663-2) / .3 mL in 1 DOSE PA... AUVI-Q HF Acquisition Co LLC, DBA HealthFirst 2012-11-15
60842-0021-02 2 DOSE PACK in 1 CARTON (60842-021-02) / .1 mL in 1 DOSE PA... Auvi-Q kaleo, Inc 2024-09-05
60842-0022-02 2 DOSE PACK in 1 CARTON (60842-022-02) / .15 mL in 1 DOSE P... Auvi-Q kaleo, Inc 2024-11-05
60842-0023-02 2 DOSE PACK in 1 CARTON (60842-023-02) / .3 mL in 1 DOSE PA... Auvi-Q kaleo, Inc 2024-09-10
71872-7173-01 1 DOSE PACK in 1 BAG (71872-7173-1) / .3 mL in 1 DOSE PACK Auvi-Q Medical Purchasing Solutions, LLC 2019-07-15
71872-7329-01 1 DOSE PACK in 1 BAG (71872-7329-1) / .3 mL in 1 DOSE PACK Auvi-Q Medical Purchasing Solutions, LLC 2024-10-25
Observed labelers: HF Acquisition Co LLC, DBA HealthFirst (5) · kaleo, Inc (3) · Medical Purchasing Solutions, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.